Details for 2016151719

Up to date per 04.04.2026

Actions

Title / Product Name

KRISTALFORMEN VON 5-(2,6-DI-4-MORPHOLINYL-4-PYRIDMIDINYL)-4-TRIFLUOROMETHYLPYRIDIN-2-AMINE, EIN PIK3 INHIBITOR

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016151719

EP Publication Number

3040333

E-Number

1040432

Language

PCT Number

Publication Date

06.07.2016 A

12.09.2018 B1

Registration Date

12.09.2018

AT Publication Date

15.10.2018

Application Date

29.09.2011

Registration Number

Priorities

01.10.2010

388721 P

09.06.2011

201161494915 P

IPC

C07D 401/04 20060101AFI20160323BHEP

Maximum Duration of Protection

29.09.2031

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

CALIENNI, John VincentNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

DE LA CRUZ, MarilynNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

FLUBACHER, DietmarNovartis Pharma AG CH-4002 BaselCH

GONG, BaoqingNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

KAPA, Prasad KoteswaraNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

KARPINSKI, Piotr H.Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

LIU, Hui2 Blue Ridge Avenue Green Brook, New Jersey 08812US

MICHEL, PascalNovartis Pharma AG CH-4002 BaselCH

MOSE, RasmusNovartis Pharma AG CH-4002 BaselCH

TESTA, Maria CaterinaNovartis Pharma AG CH-4002 BaselCH

WAYKOLE, Liladhar MurlidharNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

Information about Fees